Dr Hongchao Pan
|Tel||+44 (0)1865 743835|
Senior Research Fellow, CTSU
Hongchao Pan is a statistician and epidemiologist in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). He holds a PhD in astrophysics from University of Leicester and an MSc in epidemiology from London School of Hygiene & Tropical Medicine. Since joining CTSU in 1995, he has worked on number of large-scale randomised clinical trials (such as CAST, COMMIT/CCS2, ACST, ATLAS) and epidemiological studies.
His research interests include systemic treatments for early breast cancer, effect of obesity on breast cancer prognosis, and mortality from smoking. Dr Pan leads the meta-analysis of individual participant data of the breast cancer screening trials with mammography and the long-term follow-up of the British Doctors Study.
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39
A novel clinical risk score to identify people with asymptomatic carotid artery stenosis with a higher risk of stroke
Halliday AW. et al, (2017)
Pre-operative Carotid Plaque Echolucency Assessment has no Predictive Value for Long-Term Risk of Stroke or Cardiovascular Death in Patients Undergoing Carotid Endarterectomy.
de Waard D. et al, (2017), Eur J Vasc Endovasc Surg, 54, 135 - 141
10 vs 5 years of adjuvant tamoxifen: exclusion of 1/402 centres in ATLAS.
Davies C. et al, (2017), Lancet, 389
Ten-year risk of stroke in patients with
previous cerebral infarction and the
impact of carotid surgery in the
Asymptomatic Carotid Surgery Trial
Halliday AW. et al, (2016), International Journal of Stroke